Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 2/20 | 0.42 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 10/20 | 0.37 |
| ▸ | P4HB | P07237 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.36 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.31 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.31 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3394622 | 0.85 | CYP19A1 (0.44) | CYP19A1P4HBHIF1ACYP17A1 | |
| SCHEMBL3394201 | 0.83 | CYP19A1 (0.34) | CYP19A1P4HBCYP17A1 | |
| SCHEMBL3395050 | 0.78 | CYP19A1 (0.48) | CYP11B1CYP11B2CYP19A1P4HBHIF1A | |
| SCHEMBL3394245 | 0.71 | CYP19A1 (0.58) | CYP19A1P4HBHIF1ACYP17A1PTPN1 | |
| SCHEMBL3394928 | 0.69 | CYP19A1 (0.50) | CYP19A1P4HBHIF1APTPN1 | |
| SCHEMBL3390099 | 0.66 | CYP19A1 (0.53) | CYP11B1CYP11B2CYP19A1HIF1ACYP17A1 | |
| SCHEMBL13443147 | 0.65 | CYP11B1 (0.42) | CYP11B1CYP11B2CYP19A1P4HBCYP17A1 | |
| SCHEMBL3391074 | 0.64 | HIF1A (0.52) | HIF1ACYP17A1PTPN1 | |
| SCHEMBL13442919 | 0.63 | CYP11B1 (0.43) | CYP11B1CYP11B2CYP19A1P4HBHIF1A | |
| SCHEMBL3390882 | 0.63 | HIF1A (0.53) | HIF1APTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100087478-A1 | HIF-1 Inhibitors | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-04-08 | — | — | US | claimed |
| US-20070099952-A1 | Hif-1 inhibitors | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-05-03 | — | — | US | claimed |
| US-20100087478-A1 | HIF-1 Inhibitors | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-04-08 | — | — | US | disclosed |
| US-7652033-B2 | HIF-1 inhibitors | EMORY UNIVERSITY (US) | 2010-01-26 | — | — | US | disclosed |
| US-20070099952-A1 | Hif-1 inhibitors | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-05-03 | — | — | US | disclosed |
| US-20070099952-A1 | Hif-1 inhibitors | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-05-03 | — | — | US | disclosed |
| US-20070099952-A1 | Hif-1 inhibitors | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070099952-A1 | Hif-1 inhibitors | HIF1AN, HIF1A, EGLN2 | CYP11B1 381/4885CYP11B2 454/4885CYP19A1 1742/4885 |
| US-20100087478-A1 | HIF-1 Inhibitors | HIF1AN, HIF1A, EGLN2 | CYP11B1 381/4885CYP11B2 454/4885CYP19A1 1742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.